Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Legend Biotech (LEGN) Income towards Parent Company (2019 - 2025)

Legend Biotech filings provide 7 years of Income towards Parent Company readings, the most recent being -$8.5 million for Q4 2025.

  • On a quarterly basis, Income towards Parent Company fell 32439.07% to -$8.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$272.1 million, a 37.05% increase, with the full-year FY2025 number at -$268.4 million, down 151516.15% from a year prior.
  • Income towards Parent Company hit -$8.5 million in Q4 2025 for Legend Biotech, up from -$38.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $26284.0 in Q4 2024 to a low of -$199.1 million in Q2 2023.
  • Median Income towards Parent Company over the past 5 years was -$96.2 million (2021), compared with a mean of -$91.4 million.
  • Biggest five-year swings in Income towards Parent Company: crashed 35570.18% in 2022 and later surged 118.15% in 2024.
  • Legend Biotech's Income towards Parent Company stood at -$88.3 million in 2021, then plummeted by 53.82% to -$135.9 million in 2022, then skyrocketed by 99.89% to -$144818.0 in 2023, then soared by 118.15% to $26284.0 in 2024, then plummeted by 32439.07% to -$8.5 million in 2025.
  • The last three reported values for Income towards Parent Company were -$8.5 million (Q4 2025), -$38.5 million (Q3 2025), and -$124.2 million (Q2 2025) per Business Quant data.